Browse studies

Find your next paid study

3,226 recruiting studies matching your filters

Project EMPOWER-Neuro Developmental Disabilities (ND): Single Session Support for Parents of Children Struggling With Anxious Avoidance

This study will inform the development of a brief online program to help parents better understand and respond to anxiety-related behaviors in children with ne…

Neurodevelopmental DisordersAutism Spectrum Disorder (ASD)Attention-Deficit/Hyperactivity Disorder (ADHD)+6 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Boston University Charles River CampusNCT07898592

Phase 4

Sequential Multiple Assignment Randomized Trial to Treat Urinary Symptoms in Parkinson Disease

The purpose of this study is to learn about different treatments for overactive bladder symptoms in Parkinson's Disease. The investigators want to find out if …

Overactive BladderParkinson Disease

Estimated

~$25 – $900

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT07187466

Phase 2

A Phase 2 Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy

This phase II randomized control trial assesses the effect of Urolithin A (Uro-A) supplementation compared to placebo in men with biopsy-confirmed prostate can…

Prostate Adenocarcinoma

Estimated

~$75 – $1,800

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT06022822

Phase 1

A Phase 1B Study of Combination ATR (M1774) and BET Inhibition (ZEN003694) to Exploit ARID1A Loss in Recurrent Ovarian and Endometrial Cancer

This phase Ib trial tests the safety, side effects, and best dose of M1774 when given with ZEN-3694 in treating patients with ovarian and endometrial cancer th…

Recurrent Endometrial CarcinomaRecurrent Endometrial Clear Cell AdenocarcinomaRecurrent Endometrial Endometrioid Adenocarcinoma+6 more

Estimated

~$150 – $2,700

Actual pay is set by the research site.

Observational

Ambulatory Long Length URodynamics Evaluation

A prospective, open-label, single arm interventional trial evaluating the safety and performance of the in-clinic and extended monitoring of the lower urinary …

UrologyUrinary Bladder, OveractiveBenign Prostatic Hyperplasia+4 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Bright UroNCT07425015

Phase 1

A Phase 1 Study of ALN-BCAT as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced or Metastatic Hepatocellular Carcinoma

The purpose of the dose escalation part of the study is to characterize the safety and tolerability of ALN-BCAT as monotherapy and in combination with pembroli…

Advanced Hepatocellular CarcinomaMetastatic Hepatocellular Carcinoma

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Alnylam PharmaceuticalsNCT06600321

Phase 1

A Phase 1/2, Open-label, Multi-center, First-in-human Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Antitumor Activity of STX-003 Delivered Intravenously in Patients With Advanced Solid Tumors as a Monotherapy or in Combination With Pembrolizumab

Protocol Title: Phase 1/2, Open-label, Multi-center, First-in-human Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activi…

Advanced Solid Tumor

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Strand Therapeutics Inc.NCT07751042

Phase 1

A Dose Escalation and Dose Optimization Phase 1a/1b Study to Evaluate Safety, Tolerability and Dosimetry of Radioligand Therapy With LY4337713 in Adults With FAP-Positive Solid Tumors (FiREBOLT)

This is a study of LY4337713 in participants with certain types of cancer that is advanced or has spread. Participants must have cancer with high levels of a p…

Ovarian NeoplasmsBreast NeoplasmsPancreatic Intraductal Neoplasms+5 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Eli Lilly and CompanyNCT07213791

Phase 3

A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating the Efficacy and Safety of Empasiprubart IV in Adults With Chronic Inflammatory Demyelinating Polyneuropathy

The main purpose of this study is to demonstrate the efficacy and safety of empasiprubart in adults with CIDP. The study consists of a part A where participant…

Chronic Inflammatory Demyelinating PolyneuropathyCIDPChronic Inflammatory Demyelinating Polyradiculoneuropathy

Estimated

~$50 – $2,250

Actual pay is set by the research site.

argenxNCT07091630

Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Diseases

Selected individuals suspected of having or with prior biopsy proof of malignant disease will be seen in the Urologic Oncology Branch, NCI. Blood samples may b…

Malignant NeoplasmsHereditary Neoplastic SyndromesKidney Cancer+2 more

Estimated

~$10 – $675

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT00026884

Phase 1

A Phase 1a/b Study to Evaluate the Safety and Efficacy of OPB 201, an Autologous PReferentially Expressed Antigen of MElanoma (PRAME) T Cell Receptor (TCR) T Cell Therapy in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.

The goal of this clinical trial is to learn if OPB-201 is safe in recurrent endometrial and platinum resistant ovarian cancer participants and also to find the…

Endometrial Cancer RecurrentEndometrial CancerAdvanced Endometrial Cancer+4 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Outpace Bio, Inc.NCT07664735

Lymphoid Malignancies and Precursors: Tissue Acquisition Protocol

Background: \- Lab studies help researchers better understand cancer biology. This information may lead to new methods for diagnosing or treating cancer. To d…

Hodgkin DiseaseLymphoma, Non-HodgkinMultiple Myeloma+2 more

Estimated

~$10 – $675

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT01676805